04.03.25 -- A Look At AI-Driven Medtech For Rare Disease Diagnosis

Recent advances in AI, including machine learning, natural language processing, and deep learning models, are transforming rare disease diagnosis.

A new six-phase assessment process simplifies regulatory approval for generic drug-device combination products, reducing costs and timelines while maintaining safety and effectiveness.